Visfatin activates cell cycle progression by upregulation of cyclins and other cyclin-dependent kinases [63] and increases the synthesis of genes that play a significant role in tumor-related angiogenesis such as vascular endothelium growth factor (VEGF), in metastasis and tumor invasion as matrix metalloproteases [64]. The gene discussed is VEGFA; the disease is neoplasm.